➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Colorcon
Baxter
Harvard Business School

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Details for Biologics License Application: 125247


Email this page to a colleague

« Back to Dashboard

Summary for BLA: 125247
Tradename:THROMBIN HUMAN
Applicant:Ethicon, Inc
Ingredient:thrombin human
Patents:32
Approval Date:Sep 19, 2009
Suppliers: see list2

US Patents for BLA: 125247

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ethicon, Inc THROMBIN HUMAN thrombin human POWDER, FOR SOLUTION 125247 1 2009-09-19 ⤷  Try it Free The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (Rockville, MD) Virginia Commonwealth University (Richmond, VA) 2028-04-11 search
Ethicon, Inc THROMBIN HUMAN thrombin human POWDER, FOR SOLUTION 125247 1 2009-09-19 ⤷  Try it Free Baxter International Inc. (Deerfield, IL) Baxter Healthcare SA (Glattpark (Opfikon), CH) 2030-06-01 search
Ethicon, Inc THROMBIN HUMAN thrombin human POWDER, FOR SOLUTION 125247 1 2009-09-19 ⤷  Try it Free GEL-E, Inc. (College Park, MD) University of Maryland, College Park (College Park, MD) The General Hospital Corporation (Boston, MA) 2033-03-13 search
Ethicon, Inc THROMBIN HUMAN thrombin human POWDER, FOR SOLUTION 125247 1 2009-09-19 ⤷  Try it Free search
Ethicon, Inc THROMBIN HUMAN thrombin human POWDER, FOR SOLUTION 125247 1 2009-09-19 ⤷  Try it Free Cutter Laboratories, Inc. (Berkeley, CA) 2000-07-05 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Moodys
Dow
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.